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Abstract Heterotrimeric G proteins were purified from bovine 
brain by immunoaffinity chromatography on immobilized anti G 
protein monoclonal antibody 3C2. Release of ßy subunits was 
effectuated by exposure of immobilized trimeric G proteins to 
MgAlF4 . The resultant ßy subunits were pure and biologically 
active. Following immunization of mice with purified ßy subunits 
we obtained monoclonal anti ß antibodies showing broad species 
cross-reactivity. Characterization of the epitope recognized by 
one such monoclonal antibody, ARC9, indicated involvement of 
the extreme COOH-terminus, as assessed by its reactivity on ß 
subunits lacking the COOH-terminal 15 residues, obtained by in 
vitro translation. Although we used native ßy subunits as 
immunogen, all monoclonal antibodies obtained failed to 
recognize assembled ßy subunits, and were specific for free ß 
subunits. This property is useful in characterizing the assembly of 
G proteins from their subunits in living cells. 
Key words: Heterotrimeric G protein ß subunit; Monoclonal 
ant ibody; Immunoaffinity chromatography; Cross-reactivity; 
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1. Introduction 
Heterotrimeric G proteins (aßy) transduce signals from a 
large number of cell surface receptors to a downstream effec-
tor system [1-3]. The multiplicity of receptors and the variety 
of G protein subunits (20 oc, 5 ß, 8 y) allow tremendous com-
binatorial complexity. The specificity of receptor-G protein 
interactions determines the cellular response, which is in 
turn dependent on the intracellular machinery employed. Sep-
arate from this function in signal transduction is their role as 
regulators of intracellular trafficking events [4,5]. 
Upon activation of a receptor by an extracellular signal, 
which triggers a receptor to interact with the G protein a 
subunit, the a subunit releases G D P for G T P , resulting in 
dissociation of the heterotrimer [2]. Both subunits, a and ßy, 
can then independently regulate downstream effectors [6]. 
Numerous studies have been performed to characterize the 
specificity of G protein-receptor interactions. Cell transfec-
tions with G protein subunits and antisense oligonucleotide 
injections have been successful in identifying G protein-recep-
tor combinations capable of assembly and signaling [7,8]. 
Antibodies against each individual G protein subunit have 
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been invaluable in the studies to dissect the structure and 
function of these subunits [9-12]. Most of the immunological 
anti G protein reagents described are polyclonal reagents 
which have been raised against peptides. Such antibodies are 
highly specific for one G protein subtype, but they often fail 
to recognize their epitope under native conditions, as assessed 
by immunoprecipitation. 
Here we describe the generation of monoclonal antibodies 
(mAb) directed against the ß subunit of G proteins. These 
antibodies were raised against native ßy subunits, as obtained 
by a single-step immunoaffinity purification from bovine brain 
membranes, a method that is itself useful for obtaining sub-
units of good purity in high yield. These monoclonal antibod-
ies show a broad pattern of species and tissue specificity and 
exhibit unusual properties with respect to the epitope recog-
nized. Although mice were immunized with the native ßy com-
plex, the monoclonal antibodies recognize ß only when not 
associated with y. We mapped the epitope recognized by m A b 
A R C 9 and localized it to the COOH-terminal 15-20 amino 
acids of the ß subunit. The crystal structure obtained for ßy 
complexes confirms this region as a putative site of interaction 
for ß and y [13,14]. This unique pat tern of antibody reactivity 
can be used to score for assembly of heterotrimeric G proteins 
in living cells. 
2. Materials and methods 
2.1. Purification of G^ subunits 
2.1.1. Membrane preparation. Bovine brain membranes from 
freshly slaughtered cows were prepared as described [15]. Crude mem-
brane preparations in 10 mM Tris-HCl, pH 7.5, 10% (w/v) sucrose 
were stored at 7.5 mg/ml, at —70°C until used. All subsequent proce-
dures were done at 4°C. G proteins were extracted from 50 ml of 
brain membranes by addition of 200 ml cold Nonidet P-40/deionized 
Lubrol lysis buffer (0.5% Nonidet P-40 (NP-40), 0.1% Lubrol (ICN), 
50 mM Tris-HCl, pH 7.5, 5 mM MgCl2, 50 mM NaCl, 1 mM PMSF) 
for 45 min. Lysates were clarified by centrifugation at 11 000 rpm for 
45 min in a Sorvall SS-34 rotor. Prior to immunoisolation, the super-
natant was mixed with 1/20 volume of a 10% (v/v) solution of forma-
lin fixed Staphylococcus aureus for 1 h, followed by a centrifugation at 
11 000 rpm (Sorvall SS-34 rotor) for 1 h. 
2.1.2. Preparation of immunoaffinity columns. The Goa-specific 
mAb 3C2 (IgGl isotype) [16] was purified from hybridoma culture 
supernatant and covalently cross-linked to 20 ml protein A sepharose 
beads (RepliGen) to a final concentration of 2.4 mg/ml of gel [17]. 
Purified anti Goa/Gja mAb 3E7 was bound to 5 ml protein A sephar-
ose beads, yielding 1.8 mg antibody per ml resin. The 3E7 antibody 
retains free a subunits. 
2.1.3. Immobilization of G„ and purification of GpT. 250 ml of ly-
sate was applied to the 3C2 column equilibrated with 50 mM Tris-
HCl, pH 7.5, 1 mM EDTA, 0.015% Lubrol, 5 mM MgCl2 at a flow 
rate of 1 ml/min, followed by extensive washing ( ~ 500 ml) in equi-
libration buffer. Specific elution of ßy was carried out with 20 column 
volumes of elution buffer (50 mM Tris-HCl, pH 7.8, 1 mM EDTA, 10 
mM MgCl2, 50 mM NaCl, 20 mM A1C13, 10 mM NaF, 25 mM GDP, 
1% (w/v) cholate (Sigma)). Prior to elution, the 3E7 column was 
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connected in series to the 3C2 column to remove residual free a 
subunits from the eluted ßy subunits. After application of 2 volumes 
of elution buffer, elution was stopped for 20-30 min to allow subunit 
dissociation on the matrix. Elution was continued and fractions of 9-
10 ml were collected. Aliquots (50 ul) of each fraction were analyzed 
as described below. Columns were regenerated with glycine-HCl, pH 
2.7, followed by immediate neutralization. 
Purified ßy containing fractions were pooled and concentrated by 
pressure filtration on an Amicon concentrator (YM-10 membrane, 
cut-off 10 kDa), followed by dialysis against PBS/0.015% Lubrol 
with three changes of buffer. In some cases 0.3% (w/v) cholate and 
1 mM DTT were used in the dialysis buffer, and dialysis preceded 
concentration. Protein concentrations were determined with BCA pro-
tein assay (Pierce). 
2.2. Gel electrophoresis 
SDS-gel electrophoresis was performed as described [18] on either 
12.5%) or 15% acrylamide gels. Discontinuous 12.5%-15% gels were 
prepared by pouring the bottom third of the gel with a 15% acryl-
amide/bisacrylamide solution, which was then overlaid with a 12.5% 
solution. Tricine-SDS polyacrylamide gel electrophoresis (PAGE) was 
done as described [19], either in the variation including 6 M urea or as 
16.5%) T, 3% C gels. Polypeptides were visualized by silver staining 
[20]. Radioactively labeled samples were visualized by fluorography 
using DMSO-PPO and exposure to Kodak XAR-5 films. 
2.3. Production of poly- and monoclonal antibodies 
The monoclonal antibodies ARC1-ARC10 described in this study 
were raised as follows. 8 week old female BALB/c and C57BL/6 mice 
were injected intraperitoneally with 50 ixg native ßy in 500 |il PBS/ 
0.015% Lubrol and Freund's adjuvant in 3 weekly intervals with three 
boosts. Fusions were done according standard procedures [21], hy-
bridoma supernatant was screened in direct and indirect ELISA as 
described below. Hybridomas were cloned by limiting dilution. 
2.3.1. Direct ELISA, ßy was taken from a 20 iig/ml stock in PBS/ 
0.015% Lubrol and diluted 40-fold in 25 mM carbonate buffer (pH 
8.9). The complex was allowed to adsorb to 96 well Immunolon 
4 plates (Dynatech) overnight and unbound ßy was removed by wash-
ing with PBS/0.05%, (v/v) Tween. Plates were blocked with PBS/1% 
(w/v) gelatin at room temperature, washed and 100 uj hybridoma 
supernatant was added for 2 h. Bound antibody was detected after 
addition of peroxidase-coupled goat anti mouse antibody (Southern 
Biotechnology) and tetramethylbenzidine dihydrochloride (Sigma) 
and H2O2 as substrate. Assays were evaluated by visual inspection. 
2.3.2. Indirect ELISA. Protein A purified polyclonal rabbit anti 
ßy was adjusted in coupling buffer to 10 (ig/ml, and 100 itl were added 
per well. Unbound antibody was removed and 100 ul ßy (0.5 |xg/ml) in 
PBS/Tween was added for 2 h at room temperature. The subsequent 
procedures were identical to those described for direct ELISA. 
Antibody isotyping was also done by ELISA, employing isotype 
specific antibodies (Southern Biotechnology) coupled to plates. 
2.3.3. Polyclonal antibodies. A rabbit anti ßy polyclonal antiserum 
was raised by injecting a NZW rabbit with 250 |ig ßy in complete 
Freund's adjuvant followed by two boosts at 3 weekly intervals con-
taining 250 |xg ßy in incomplete adjuvant administered subcutane-
ously. IgG antibodies were purified on FPLC (Pharmacia) by protein 
A sepharose chromatography. 
A polyclonal rabbit anti y antiserum was raised against a synthetic 
peptide (CEAHAKEDLLTPVPASENPF), covering a common y2 and 
y3 sequence. This peptide was synthesized on a multiple peptide syn-
thesizer (Advanced Chemtech, model 350), employing conventional 
Fmoc chemistry. Using the heterobifunctional crosslinker SMPB 
(Pierce) a bovine serum albumin conjugate was generated and this 
complex was injected into a rabbit, as described for the ßy antibodies. 
The polyclonal rabbit anti ßi antiserum U-49 was raised as described 
[22] (gift of Dr. S. Mumby, Dallas, TX). 
2.4. In vitro transcription and in vitro translation 
cDNA constructs (kindly provided by Dr. M. Simon, Pasadena, 
CA) encoding ßi and ß2 were transcribed using SP6 (ßi) or T7 (ß2) 
RNA polymerase (Promega). The optimal amount of RNA needed 
for translation was determined empirically for each separate chain. In 
vitro translations in rabbit reticulocyte lysate (Promega) were essen-
tially done as described [23]. Translations were performed for 2 h at 
30°C and terminated by addition of Nonidet P-40 lysis buffer (50 mM 
Tris-HCl, pH 7.5, 5 mM MgCl2, 0.5% NP-40). 
mRNAs encoding COOH-terminal truncations of the ßi chain were 
generated by restriction enzyme digestion of the full length cDNA 
with PvuII, Dsal, Nsil and Bgñ\ respectively. Such linearized plasmids 
were used for the transcription of mRNA [24], 
2.5. Immunoblotting 
Polypeptides were resolved on gel systems as indicated in the figure 
legends and blotted either to nitrocellulose (0.45 11m pore size, Bio-
Rad) or to PVDF (Immobilon-P, Millipore). The blots were incubated 
with the first antibodies (see figure legends), followed by horseradish 
peroxidase coupled goat anti mouse or horseradish peroxidase 
coupled goat anti rabbit immunoglobulin (Ig) (Southern Biotechnol-
ogy) antibody. Bound antibody was visualized by chemoluminescence 
(ECL detection kit, Kirkegaard and Perry) and exposure to Kodak 
XAR-5 films. 
2.6. Preparation of tissue homogenates 
Small scale preparations of crude brain membranes from mouse, 
rat, and Xenopus laevis were performed as described [16]. Adult zebra-
fish were decapitated, heads were freeze-thawed three times and ho-
mogenized in 10 mM Tris-HCl, pH 7.4, 250 mM sucrose, 1 mM 
EDTA using a Polytron mixer. The homogenate was centrifuged at 
500Xg at 4°C for 10 min. Subsequently, the supernatant was centri-
fuged at 100 000 Xg for 1 h at 4°C. The resulting pellet was resus-
pended in 10 mM Tris-HCl, pH 8.0, 2 mM MgCl2. Caenorhabditis 
elegans membrane preparation was essentially as described [25], Dro-
sophila melanogaster was homogenized identically to the procedure 
used for zebrafish. Yeast cell homogenate was provided by Drs. F. 
Solomon and L. Vega (Cambridge, MA). Protein concentration was 
determined by the method of Bradford. 
2.7. GST fusion protein 
The expression of the glutathione 5-transferase (GST)-BTK (PH) 
fusion protein (222 amino-terminal amino acids) in E. coli was essen-
tially as described [26] (construct kindly provided by Drs. F. Alt and 
W. Khan, Boston, MA). This construct was introduced into E. coli 
and overexpression of the fusion protein was induced with isopropyl-
1-thio-ß-D-galactopyranoside (Sigma). To purify the fusion protein 
glutathione-sepharose beads (Pharmacia) were added to the bacterial 
lysate in NET-N buffer (20 mM Tris-HCl, pH 8.0, 100 mM NaCl, 
0.5% NP-40) supplemented with 1 mM PMSF, 50 mM EDTA. Fusion 
proteins were eluted by competition with 5 mM reduced glutathione 
(Sigma), and subsequently screened for integrity on SDS-PAGE and 
silver staining. GST-ß ARK 1 fusion protein was provided by Drs. R. 
Lefkowitz and R. Stoffel (Durham, NC). 
Detection of ßy binding to GST-ß ARK 1 and GST-BTK (PH). 
This assay was done as described [27]. 
2.8. Tryptic cleavage 
Purified ßy complexes (4-6 (ig) were treated with 5 itg of L-1-tosyl-
Fig. 1. Immunoaffinity purification of G p r Bovine brain membrane lysates were loaded on a column coupled with mAb 3C2. After extensive 
washing a smaller column coupled with mAb 3E7 was connected in series to remove further a subunits upon elution. The ßy subunits were 
eluted with a cholate buffer containing MgAlF4 and GDP, and analyzed by SDS-PAGE. Polypeptide chains were visualized by silver staining 
or detected by immunoblot. A: Eluted samples (1/200 of each fraction) were loaded on a 12.5% SDS-PAGE and stained with silver. Lane 1, 
NP-40/Lubrol extract from bovine membranes; lane 2, flow through fraction; lane 3, washing fraction; control lane with purified ßy pooled 
from peak fractions 2-12. B: Immunoblot of purified ß subunits. 50 ill aliquots of purified ßy complex containing fractions were subjected to 
electrophoresis on a 12.5% SDS-PAGE and transferred to nitrocellulose. The blotting membrane was incubated with an anti Gp mAb (ARC5). 
Lanes designated as in A. C: 30 ill aliquots of eluate fractions subjected to 16.5% T, 6% C, 6 M urea Tris-tricine gel electrophoresis, polypep-
tides were stained with silver. D: Aliquots of purified ßy complexes were resolved on Tris-tricine gel electrophoresis, transferred to PVDF, and 
detected with an anti y2, y3 polyclonal antibody. E: Schedule for the purification of ßy subunits used for the generation of mAbs. 
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amido-2-phenylchloromethyl ketone treated trypsin (Sigma) at 30°C 
for 30 min in 100 ul 50 mM Tris-HCl, pH 7.6, 2 mM MgCl2, 0.1 mM 
EDTA, 0.5 mM DTT, 0.075% (w/v) Lubrol. The reaction was stopped 
by adding 4 X Laemmli sample buffer and boiling for 5 min. 
For immunoprecipitation tryptic digestion was stopped by addition 
of 10 X excess (w/w) trypsin inhibitor (Sigma). 
2.9. Cell culture, metabolic labeling and immunoprecipitations 
All cell lines were routinely grown in DME medium, supplemented 
with 10% FCS, L-glutamine (2 mM), penicillin (1:1000 dilution U/ml) 
and streptomycin (100 ug/ml). Species and tissue origin of the cell 
lines employed are as follows: 
U-937 (histiocytic lymphoma, human), IMR-32 (neuroblastoma, 
human), Glc-2 (small lung cell carcinoma, human), COS-1 (kidney, 
SV-40 transformed, African green monkey), BC3H1 (brain tumor, 
smooth muscle-like, mouse), SW 1088 (astrocytoma, human), Jurkat 
(acute T cell leukemia, human), Neuro-2A (neuroblastoma, mouse). 
Adherently growing cells were grown to subconfluence, incubated 
for 45 min in methionine and cysteine free DME medium, and then 
labeled with [35S]methionine/cysteine (Express protein labeling mix, 
NEN) as indicated in the figure legends. For overnight labeling, 50-
75 uCi were added to a 10 cm diameter Petri dish of adherently 
growing cells or to 107 cells in suspension. Cells were lysed in 1.5 
ml NP-40/Lubrol (50 mM Tris-HCl, pH 7.5, 5 mM MgCl2, 0.5% 
NP-40, 0.1% Lubrol, 1 mM EDTA, 1 mM PMSF) lysis buffer. After 
45 min at 4°C lysates were depleted of nuclei and cell debris by 
centrifugation for 10 min at 14000 rpm in an Eppendorf centrifuge, 
and then precleared twice with normal rabbit serum and S. aureus. 
Immunoprecipitations for recovery of ß subunits were done with 4-5 
ul ascites of ARC5 or ARC9 mAb, SDS was added as indicated in the 
figure legends. Immune complexes were precipitated by adsorption to 
5. aureus, followed by 4-5 washes in NET buffer (50 mM Tris-HCl, 
pH 7.5, 5 mM EDTA, 150 mM NaCl, 0.5% NP-40). 
3. Results 
3.1. Immunoaffinity purification of Gßy subunits 
To produce monoclonal antibodies against native ßy sub-
units a rapid purification procedure using immunoaffinity 
chromatography was developed. The anti Goa specific mAbs 
3C2 and MONO [16] can interact with heterotrimeric G pro-
teins under native conditions and either of these antibodies 
could be used for the capture of milligram quantities of bo-
vine brain G proteins. We prepared an affinity column 
coupled with mAb 3C2, resulting in a theoretical binding ca-
pacity of 0.32 umol heterotrimeric G proteins. Elution of ßy 
subunits from this affinity column could be accomplished by 
several methods, amongst which were the exposure to GTP-y 
Fig. 2. Immunoaffinity purified ßy subunits interact with GST-ß 
ARK 1 and GST-BTK(PH) fusion proteins. 5 ug immunoaffinity 
purified ßy in PBS/0.015% Lubrol was incubated with either an 
equal quantity of GST-ß ARK 1 or with GST-BTK(PH) of two dif-
ferent preparations (7,8). Complexes were washed and loaded on a 
12.5% SDS-PAGE, transferred to nitrocellulose and immunodetec-
tion of bound ß subunits was accomplished using mAb ARC5. Puri-
fied ßy was used as a positive control, and GST alone served as a 
negative control. 
Fig. 3. Specificity of the anti ßy monoclonal antibodies. A: Mem-
branes were prepared from tissue homogenates of the species indi-
cated as described in Section 2. 100 ug of membrane proteins was 
analyzed by 12.5% SDS-PAGE, blotted to nitrocellulose and incu-
bated with ARC5 (ascites 1:1000). 1 |ig purified bovine brain G 
protein was used as control. The reactivity with C. elegans remains 
marginal even when tested at higher protein concentrations. All anti 
Gp antibodies (ARC2, 5, 9) showed a comparable pattern of reac-
tivity. B: Cell lines were labeled overnight with 35S]methionine and 
lysed in NP-40/Lubrol. SDS was then added at a concentration of 
0.1%, and ß subunits were immunoprecipitated using mAb ARC9. 
S or MgAlF 4 in the presence of G D P . Prior to elution of the 
3C2 resin, a second immunoaffinity column, prepared with the 
anti Go c t /G i a m A b 3E7 was connected in series with the 3C2 
matrix. The 3E7 antibody induces dissociation of the brain G 0 
protein by interacting with a0 and displacing ßy, and also 
binds free a subunits with high affinity [12]. By connecting 
the 3E7 column in series, any residual a subunit or trimers 
present in the 3C2 eluate were removed. 
The resulting fractions contained electrophoretically pure ß 
and y subunits, as visualized by silver staining (Fig. 1 A,C) and 
immunoblotting using a ß specific mAb (ARC5, to be de-
scribed below, Fig. IB) and a j2, Y3 specific polyclonal anti-
body (Fig. ID). Gy subunits could be further separated on an 
alternative Tris-tricine gel system, so that the heterogeneity of 
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different y subunits was revealed (A. Rehm and H.L. Ploegh, 
unpublished observation). We conclude that the ßy prepara-
tion obtained was heterogeneous with respect to y composi-
tion, in agreement with published data [28,29]. The purifica-
tion yielded 1.4 mg of ßy complexes starting from 375 mg of 
membrane protein, which represents approximately 10% of 
the theoretical binding capacity of the column, and a yield 
of approximately 70% based on the assumption that 1% of 
membrane protein consists of G proteins. Prior to concentra-
tion, the pooled peak fractions contain ßy in a concentration 
of up to 18 |ig/ml (concentrations in individual peak-fractions 
will be considerably higher). Concentrated and dialyzed prep-
arations of ßy thus obtained were used as immunogen for the 
production of both poly- and monoclonal antibodies (Fig. 
IE). 
3.2. Production of ant i ßy antibodies 
Immunopurified ßy subunits were examined for their bio-
logical activity by taking advantage of the known ability of ßy 
subunits to interact with ß-adrenergic receptor kinase (ß 
ARK1) and BTK, two kinases that possess pleckstrin homol-
ogy domains (PH domains) implicated in the interaction with 
ßy [27,30,31]. The GST-fusion protein construct for BTK con-
Fig. 5. Recognition of ß by mAb ARC9 and the presence of y sub-
units are mutually exclusive. A: Bovine brain membranes were lysed 
in NP-40/Lubrol. Immunoprecipitations with mAb ARC 9 were 
done in the presence of variable concentrations of SDS, followed by 
separation on a discontinuous 12.5%-15% SDS-PAGE. Polypeptides 
were transferred to PVDF and detected with a mixture of an anti 
Gp mAb (ARC5) and a polyclonal anti G y2, y3 antibody. The posi-
tions of ß chain, y chain and antibody light chain are indicated on 
the right. Control lanes contain 1 u,g purified ßy subunits from 
pooled fractions (aliquots taken before and after dialysis, see Sec-
tion 2). B: G protein ßi and ß2 subunits were translated in vitro 
and analyzed for reactivity with mAb ARC9 in the presence (+) 
and absence (—) of 0.2% SDS. Total translation products and im-
munoprecipitates were loaded on a 12.5% SDS-PAGE. 
Fig. 4. The recovery of G protein ß subunits in immunoprecipita-
tions requires SDS. A: Bovine brain membranes (7.5 mg/ml) were 
lysed as in Fig. 1. Aliquots of lysate were then exposed to different 
concentrations of SDS, ranging from 0 to 0.4% (w/v) as indicated. 
MAb ARC9 was used to immunoprecipitate ß subunits. The posi-
tion of ß is indicated on the right. Samples were analyzed on a 
12.5% SDS-PAGE (A, B). B: IMR-32 neuroblastoma cells were 
metabolically labeled overnight with [35S]methionine. Lysates were 
first prepared in NP-40/Lubrol buffer, and SDS was then added to 
the concentrations indicated. Gp subunits were recovered using mAb 
ARC9, normal mouse serum (nms) served as a negative control. C: 
ARC9 recognizes the ß subunit after dissociation of the y subunit 
induced by SDS. 
tains the N-terminal unique region (222 amino acids) and 
covers the PH domain, which is composed of the first 137 
amino acids. The ßy subunits prepared by immunoaffinity 
purification were capable of interacting with both ß ARK1 
and BTK (Fig. 2), confirming their biological activity. 
Using ßy subunits purified by immunoaffinity chromatogra-
phy, polyclonal antibodies were raised in rabbits (Fig. IE). 
The purified IgG fraction of a polyclonal antiserum was 
then used for indirect ELISA as capture reagent for purified 
ßy and for immunoblotting. 
Following immunization of mice, 10 stable antibody-pro-
ducing hybridomas (ARC1-10) were obtained from two fu-
sions, eight of which turned out to be of the IgM isotype. 
Because of the limited usefulness of the IgM antibodies for 
biochemical analysis much of the further immunochemical 
characterization was carried out with the IgG isotype reagents 
ARC5 (IgGl) and ARC9 (IgG3) and with the polyclonal 
rabbit anti ßy serum. 
3.3. Specificity of the anti ßy monoclonal antibodies 
The specificity of three mAbs was examined using immuno-
blots. First, the antibodies ARC2 (IgM), ARC5 (IgGl), and 
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Fig. 6. Epitope recognition of ARC5, ARC9 and rabbit anti ßy serum. A: Purified ßy complexes (4-6 ug) were digested with trypsin as de-
scribed in Section 2. Samples were loaded on a 12.5% SDS-PAGE, transferred to nitrocellulose and detection of ß chains and tryptic fragments 
was accomplished using the antibodies U-49 (1:10000), ARC5 (1:1000), and rabbit anti ßy serum (1:20000). ARC5 and ARC9 both recognize 
the COOH-terminal 27 kDa fragment (data shown for ARC5). B: Tryptic cleavage of ßy (4-6 (ig) complexes removes y subunits from the 27 
kDa fragment and allows epitope recognition in the absence of SDS. After trypic digestion immunoprecipitations were performed in the ab-
sence and presence of SDS using ARC9. Immunoprecipitates were resolved on 12.5% SDS-PAGE, transferred to nitrocellulose and detection of 
full length ß chains and tryptic fragments was done with ARC5. (Note that the arrow indicates an artifact, upon inspection of duplicate blots 
there is no immunoprecipitation product of full length ß in the absence of SDS). C: mRNAs encoding the full length ßi chain (340 amino 
acids) or COOH-terminally truncated forms (C) were translated in vitro using reticulocyte lysate. Lysates were divided and subjected to immu-
noprecipitation with mAb ARC9 and polyclonal rabbit anti ßy serum (R). Immunoprecipitates were analyzed on 12.5% SDS-PAGE. The 56 
amino acid long truncated ß chain does not resolve in this gel system and runs with the dye-front as indicated (*). D: Amino acid sequence 
alignment of ß subunits from different species. Alignment is based on the homology of four ß subunits comprising the WD-40 repeat 7 (single 
letter code). Substitutions in Drosophila and yeast compared to bovine ßi are printed in capital letters, homologies are indicated by dashes. 
Residues important for specific interactions with y subunits are boxed. 
ARC9 (IgG3) all recognized a polypeptide doublet at 35 and 
36 kDa in crude brain membrane extracts of bovine origin 
(Figs. 1 and 3A, data shown for ARC5), clearly distinguish-
able from the polypeptide stained by anti G a antibody 3E7 
(data not shown). Second, ARC2, ARC5 and ARC9 reacted 
with a 35/36 kD polypeptide doublet present in highly purified 
G protein preparations (Fig. 3A). 
When analyzing the pattern of reactivity of the ARC2, 
ARC5 and ARC9 on crude membrane preparations from a 
variety of species (shown for cow, Xenopus, C. elegans, yeast, 
Drosophila, mouse, rat, zebrafish in Fig. 3A), we observed 
reactivity not only with G proteins from the immunizing spe-
cies, but also with ß subunits from Xenopus, zebrafish, mouse, 
and rat. Marginal reactivity was observed for C. elegans, while 
no reactivity was seen for Drosophila and yeast. This survey 
was not extended beyond the species documented, nor have 
the conditions for preparation of the appropriate homoge-
nates been optimized. 
All mammalian cell lines examined, regardless of cell type 
or tissue origin, revealed strong immunoreactivity in immuno-
blot and immunoprecipitation (Fig. 3B). 
3.4. G protein ß subunits are recovered from non-ionic 
detergent-lysates upon exposure to SDS 
Our initial attempts to immunoprecipitate ßy subunits from 
35S-labeled cell lysates were unsuccessful, and contrasted with 
the reactivities of total cell extracts prepared from the same 
cells in immunoblots (data not shown). Even though the ini-
tial immunizations were performed with ßy not previously 
exposed to denaturants and of proven biological activity, 
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these results suggested that the mAbs might preferentially 
recognize free ß subunits, as generated following exposure 
to SDS. To examine whether association of ßy influences the 
reactivity of the ARC antibodies, we immunoprecipitated ßy 
subunits from bovine brain membranes, following solubiliza-
tion in NP-40/ Lubrol and exposure to SDS (Fig. 4A). We 
observed an increase in the reactivity of ARC9 with ß sub-
units starting at 0.06% of SDS with maximal recovery at 0.2-
0.4% SDS. Similar results were obtained with mAb ARC5 
(data not shown). Although ß and y subunits are considered 
a functional and structural complex, we failed to recover y 
subunits as co-immunoprecipitates in assays using ARC5 or 
ARC9 in the presence of these low concentrations of SDS. 
Similar samples analyzed on 15% SDS-PAGE gels and on 
Tris-tricine gels confirmed the recovery of ß, whereas y could 
not be detected. 
The ability of ARC5 and ARC9 to recognize ß subunits 
upon exposure to SDS, as well as their suitability for immu-
noblotting procedures suggest that they recognize epitopes 
that require unfolding of the ß subunit, or that are masked 
when y subunits are present. 
3.5. Detection of metabolically labeled ß subunits 
When cells were metabolically labeled overnight with 
[35S]methionine and immunoprecipitates were prepared with 
ARC5 or ARC9 from non-ionic detergent lysates, only 
weak signals were obtained for the ß subunits. Inclusion of 
MgAlF4 in the lysate did not improve recovery (data not 
shown), a result consistent with the suggestion that mAbs 
ARC5 and ARC9 recognize the unfolded ß subunit, or require 
release of the y subunit to allow epitope recognition. 
Addition of increasing concentrations of SDS to metabol-
ically labeled IMR-32 cell lysates resulted in enhanced recov-
ery of the ß subunit (Fig. 4B). Optimal recovery was obtained 
by addition of SDS to a final concentration between 0.2% and 
0.4% SDS, whereas the minimal requirement for SDS was 
0.05%. Few if any ß subunits were detected in the absence 
of SDS. The amount of cells used for these titration experi-
ments was kept constant to maintain a fixed protein-detergent 
ratio. Under these conditions, other multimeric proteins such 
as MHC class I molecules still retain their quaternary struc-
ture [32], as evident from their resistance to extraction or 
washing in 0.1% SDS. We suggest that this relatively mild 
treatment with the strong detergent SDS is likely to result in 
the selective loss of y subunits (Fig. 4C). 
Further evidence for the conclusion that y exerts a masking 
effect on the epitopes recognized by ARC5 or ARC9, is pro-
vided in Fig. 5A. Bovine brain membranes were first lysed in 
NP-40/Lubrol, followed by immunoprecipitation with ARC9 
in the presence of different concentrations of SDS. Samples 
were resolved on a discontinuous 12.5%-15% SDS-PAGE gel 
and blotted onto PVDF. The ß subunits were visualized with 
ARC5, whereas y subunits were detected with rabbit anti y2, j3 
serum. We observed increased recovery of ß starting with 
0.04% SDS and maximal recovery at 0.2-0.4% SDS. Although 
the quantity of ß precipitated at 0.2% SDS is comparable to ß 
in both control lanes containing purified ßy, we failed to de-
tect y in the immunoprecipitates by immunoblotting, yet these 
y subunits are easily detected in unfractionated ßy complexes. 
3.6. In vitro translation of Gß subunits 
The in vitro translation system provides properly con-
formed polypeptides capable of exerting enzymatic functions, 
i.e. receptor kinases like BTK and TSK can mediate auto- and 
transphosphorylation reactions (A. Rehm and H.L. Ploegh, 
unpublished observation). Accordingly, ß and y subunits 
translated in vitro are capable of assembly, albeit inefficiently 
[33,34]. 
When ßi and ß2 were translated in vitro using reticulocyte 
lysate, and immunoprecipitations were performed with ARC9 
in buffer containing either NP-40 or supplemented with 0.2% 
SDS, recovery of ß was equal under both conditions (Fig. 5B). 
Therefore, free ß subunits translated in vitro can be recog-
nized after solubilization in non-ionic detergent buffer and 
do not require SDS for recognition by ARC9. 
3.7. Identification of epitopes recognized by ARC5 and ARC9 
The epitope recognized by ARC5 and ARC9 was mapped 
to the COOH-terminal 15-20 amino acids, based on the abil-
ity of ARC5 and ARC9 to recognize the COOH-terminal 27 
kDa tryptic fragment, but not the NH2-terminal 14 kDa frag-
ment, and the failure to recognize a truncated ß chain, lacking 
the 15 COOH-terminal residues, obtained by in vitro trans-
lation (Fig. 6A,C). The polyclonal rabbit anti ßy antiserum 
recognized exclusively the 14 kDa NH2-terminal fragment, 
consistent with the observation that a truncated 56 amino 
acid comprising NH2-terminal fragment, as obtained by in 
vitro translation, was immunoprecipitated (Fig. 6A,C). The 
presence of the strongly labeled 30 kDa fragment visible in 
in vitro translations we attribute to premature termination of 
translation, because this fragment is reactive with the rabbit 
anti ßy serum, but not with ARC9. The size difference be-
tween the 325 amino acid truncated ß and the full length ß 
(340 amino acids) is not evident in this gel, but can be readily 
visualized by comparing the respective input mRNAs on gel. 
The tryptic cleavage of ßy complexes leaves y intact, which 
is found in association with the 14 kDa fragment. Accord-
ingly, the 27 kDa fragment could be immunoprecipitated in 
the absence of SDS (Fig. 6B). At least qualitatively, we may 
infer that removal by trypsin of the 14 kDa NH2-terminal 
fragment exposes the ARC9 epitope in the absence of SDS. 
Inspection of ß sequences suggest that the ARC5/ARC9 
epitope involves the COOH-terminal WD40 repeat (Fig. 6D). 
4. Discussion 
To generate monoclonal antibodies against native ßy sub-
units we developed a rapid isolation procedure that provided 
us with highly purified ßy subunits and that may prove to be 
generally useful. The elution of ßy by application of MgAlF4 
yielded a preparation that contained pure and biologically 
active ßy complexes, as demonstrated by immunoblot, silver 
staining and binding to GST fusion proteins in vitro (Figs. 1 
and 2). Our antibody based immunoaffinity purification read-
ily tolerates minor modifications with respect to Mg2+, Al3+, 
F~ and GDP concentrations in the elution buffer. We could 
induce complete release of Goa from the antibody resin in the 
presence of glycine-HCl (pH 2.7) for regeneration of the col-
umn. Analysis by gel electrophoresis revealed that these a 
subunits were completely devoid of ßy (data not shown). 
This is probably due to the relatively low affinity of Goa for 
ßy subunits [35,36]. 
Although the immunogen raised to generate both poly- and 
monoclonal reagents was the biologically active purified ßy 
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preparation, we were surprised to see that none of the anti-
bodies produced showed any significant reactivity with native 
ßy subunits, either derived from bovine brain membranes or 
from metabolically labeled cells, as assessed by immunopreci-
pitation. The purification protocol used to recover ßy did not 
employ denaturants or extremes of pH, and neither did the 
ELISA to screen hybridoma supernatant. This aspect will be 
discussed further below. 
The reactivity of ARC5 and ARC9 with ßy subunits from 
different species reveals that Drosophila and yeast ß, which do 
not react with the anti ß mAbs, exhibit highest divergence in 
the 40 amino-terminal amino acids and in the carboxy-termi-
nal WD 6/WD 7 domain compared to vertebrate ßs [25]. 
Both regions contribute to a large number of interactions at 
the ßy interface [13]. Specifically, Phe-64 in the COOH-termi-
nal portion of G ty forms extensive hydrophobic interactions 
with Gtß. Residues involved in the COOH-terminus of ß are 
in sheet 7, and include Ile-338 and Ala-326. 
We used a combination of in vitro translation and tryptic 
cleavage to demonstrate that the reactivity of the mAb ARC9 
mapped to the COOH-terminal 15-20 amino acids of ß (Fig. 
6A,C). Upon inspection of the published structure we con-
clude that a domain on ß located here is likely to be accessible 
to antibodies only after dissociation of y [13]. Moreover, ap-
pearance of trypsin-sensitive ßy complexes in the course of 
biosynthesis correlates with loss of antibody reactivity (A. 
Rehm and H.L. Ploegh, submitted). The COOH-terminal 6 
residues of y and its attached isoprenoid moiety can poten-
tially form a stable conformation in the presence of mem-
branes [13], and membrane attachment obviously does not 
interfere with interactions of ß and y polypeptide chains. Fur-
ther evidence for the suggested location of the epitope is pro-
vided by the observation that after tryptic digestion of ßy 
complexes the resulting 27 kDa fragment can be immunopre-
cipitated in the absence of SDS, whereas the intact ß chain 
associated with y requires SDS to be recognized (Fig. 6B). The 
27 kDa COOH-terminal derived tryptic fragment is devoid of 
y, the latter is found in association with the NH2-terminal 14 
kDa fragment of ß [37,38]. 
Alteration of a conformational epitope upon isoprenylation 
of the large hepatitis delta antigen has been observed [39]. We 
cannot formally discriminate between the y polypeptide or the 
isoprenoid moiety attached to its COOH-terminus masking 
the epitope. An in vitro translation system using ß cotrans-
lated with isoprenylation resistant y could not be used to 
prove modification independent ß recognition, since this sys-
tem does not support quantitative assembly, and levels of 
unassembled ß subunits by far exceed those which are com-
plexed (A. Rehm and H.L. Ploegh, unpublished observation). 
Transfections of cells with isoprenoid-resistant y subunits are 
likewise inconclusive, since the ARC antibodies react with all 
ß subunits tested so far and endogenous and transfected y 
subunits can not be readily discriminated. 
In conclusion, we have developed a rapid and simple pro-
cedure for the purification of native ßy subunits, which en-
abled us to generate monoclonal antibodies with unexpected 
properties. Two representative examples, the antibodies 
ARC5 and ARC9, exhibit an unprecedented broad species 
and tissue specificity. These antibodies are useful for immuno-
blotting and immunoprecipitation studies on cells from a va-
riety of species, which make them convenient tools to study G 
protein function and transport in living cells. ARC5 and 
ARC9 recognize their epitopes on ß only after dissociation 
of y. This property should be useful to study assembly events 
of heterotrimeric G proteins in cells during the course of bio-
genesis, a quality of importance for understanding how spe-
cific signaling cascades are put together and maintained. 
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